Search Results 191-200 of 18326 for IUD

  1. CardiolRx In Recurrent Pericarditis Following IL-1 Blocker Cessation - Mayo Clinic

    ... intrauterine device (IUD); intrauterine hormone-releasing system (IUS); using double-barrier contraception methods with their partners; bilateral tubal ...

  2. Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents - Mayo Clinic

    The two methods of reliable contraception must include one highly effective method (i.e. intrauterine device (IUD), hormonal [birth control pills ...

  3. A Study to Evaluate Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer - Mayo Clinic

    Intrauterine device (IUD);; Intrauterine hormone-releasing system (IUS);; To have a vasectomized sexual partner(s) (the vasectomized partner[s] has received ...

  4. Publications - Rupan Sanyal, M.D. - Mayo Clinic

    Pregnancy and IUD in different horns of the uterus. J Clin Ultrasound 2007 Jan; 35 (1):40-1. View PubMed; Taori K, Sanyal R, Rathod J, Mahajan S, Jajoo G ...

  5. Zaraq Khan, M.D. - Doctors and Medical Staff - Mayo Clinic

    Intrauterine device method; Intrauterine insemination · Minimally invasive surgery · Myomectomy; Ovary transplant; Ovulation induction; Pelvic exam; Polypectomy ...

  6. A Study to Evaluate the Effectiveness and Safety of an Amikacin Liposome Inhalation Suspension-based Regimen in Adults with Nontuberculous Mycobacterial Lung Infection - Mayo Clinic

    - copper intrauterine device IUD, - hormonal methods (levonorgestrel-releasing intrauterine system, progestogen implant, combined oral contraceptive pill ...

  7. Low-level Laser and Lifestyle Modifications (LLLT) - Mayo Clinic

    Intrauterine device (IUD);; Total hysterectomy or tubal ligation;; Abstinence (no sex). Htory of any major cardiovascular events including heart valve disease ...

  8. A Study of the Long-Term Safety, Tolerability, and Effectiveness of Tesevatinib for Patients Completing 24 Months of Treatment for Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Participation eligibility · IUD plus one barrier method · Stable doses of hormonal contraception for at least 3 months (eg, oral, injectable, implant, transdermal) ...

  9. A Study of Mavacamten in Patients with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICK-HCM or EXPLORER-HCM Trials - Mayo Clinic

    intrauterine device (IUD);; intrauterine hormone-releasing system (IUS);; bilateral tubal occlusion;; female is surgically sterile for 6 months or ...

  10. A Study to Evaluate Lamprene (Clofazimine) to Treat Non-Tuberculous Mycobacterial (NTM) Infections - Mayo Clinic

    Use of oral, (estrogen and progesterone), injected or implanted hormonal methods of contraception or placement of an intrauterine device (IUD) or ...